D.E. Shaw & Co
THRN

D.E. Shaw & Co’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

D.E. Shaw & Co’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,224
Closed -$175K – 6110
2021
Q4 		$175K Buy
+28,224
New +$221K ﹤0.01% 4930

Other funds holding THRN

DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

D.E. Shaw & Co's THRN Position: Q1 2022 in Review

D.E. Shaw & Co sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q1 2022, closing a stake of 28,224 shares — an estimated $175K sold.

D.E. Shaw & Co first reported a position in THRN in Q4 2021 and held it in 1 quarter. The position peaked at $175K in Q4 2021. 48 funds tracked by Wall St. Rank hold THRN as of Q1 2022.

  • D.E. Shaw & Co reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 28,224 Thorne Healthtech, Inc. Common Stock shares in Q1 2022, an estimated $175K.
  • D.E. Shaw & Co first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • D.E. Shaw & Co's Thorne Healthtech, Inc. Common Stock position peaked at $175K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.